Insiders Trades
innoscripta SE Stock: price and insider trades · Germany
1 insider bought €2.8M of shares over the last 90 days, the latest filed 03 Sept 2026.
innoscripta SE: what insiders have been doing
Headquartered in Munich, Germany, innoscripta SE belongs to the Technology sector and traces its origins to 2012. Filings by its managers are published through BaFin. From 18 October 2025 to 18 October 2026, the disclosure feed for innoscripta SE logged 19 filings by 2 insiders.
Only purchases show up on the open market, 19 purchases in all worth €13.9M, filed by 2 insiders. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. One trade stands out by size: a purchase of €5.5M from Hohenester Beteiligungs-UG (haftungsbeschränkt), disclosed on 10 March 2026, or 0.60% of market capitalisation.
Within a 30-day window, 7 purchases overlapped with buying by a second insider. Purchases made close together by different insiders form what is called a cluster. The latest purchase dates back some time: it was published 44 days ago, on 3 September 2026. Filings reach the BaFin feed a median of 4 days after the trade. For comparison, MAR article 19 gives managers three business days to notify a trade.
For context, the typical company on the same exchange (median of 287 companies) published 5 filings over the same period, against 19 filings here. Looking back to 2025, when coverage begins, insiders filed 27 purchases and no sales.
Other companies in the same sector with recent insider buying flagged by our signals: Core Scientific, Inc./tx and Gitlab Inc. Source: insider filings from BaFin. Past trades are no guide to future returns.
Key facts
Headquarters: Munich, Germany · Founded: 2012
Source: Wikidata (CC0).
Insider Decl.
27
Thresholds
n/a
Buy Volume
€16M
27 ops. · all time
Sell Volume
n/a
n/a
Who traded when
BuySaleHohenester Beteiligungs-UG (haftungsbeschränkt)21 buys
Meyer Beteiligungs-UG (haftungsbeschränkt)7 buys
Since the insiders bought
- -43.0%Entry €81.70 · Close at T+30 €46.60
- -18.5%Entry €81.10 · Close at T+90 €66.10
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Analyst consensus: bullish or bearish?
Analysts rate innoscripta SE Strong Buy (bullish), based on 1 analysts. Average price target: €207.21.
Fundamental score
Ranked 232 of 24,148 companies
87.4
score / 100
Value82
Quality93
FCF yld9.6%
Earn yld10%
EV/EBITDA6.9x
ROE156%
Gross mgn74%
Net mgn41%
Debt/EBITDA0.2x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€42.55
Analyst consensus
1 analystsStrong buy
€207.21Target €207.21(+387%)€207.21
Income statement
Revenue€103.4M
Gross profit€77.0M74% margin
EBITDA€63.8M62% margin
Net income€42.6M41.9% margin
Valuation
PER (trailing)7.9x
PER (forward)1.4x
P/Book11.1x
Balance sheet & cash
Market cap€425.5M
Total debt€12.5M
Free Cash Flow€40.6M
Debt / Equity30%
Profitability & ownership
ROE156.5%
ROA66.9%
% insiders84.7%
% institutions6.3%
Last declaration on 3 September 2026
Declarations27 total
15,000 shares@ €80.000.14% mcap8.0% of flowShareISIN DE000A40QVM8BAFIN:40035913-7455bf60f77d
Canonical exit: 1 Dec 2026 (T+90)
10,000 shares@ €81.250.095% mcap5.4% of flowShareISIN DE000A40QVM8BAFIN:40035913-e2a07ebf9d1f
Canonical exit: 29 Nov 2026 (T+90)
10,000 shares@ €73.900.087% mcap4.9% of flowShareISIN DE000A40QVM8BAFIN:40035913-c5fb7a734cc7
Canonical exit: 24 Nov 2026 (T+90)
78,900 shares@ €70.000.60% mcap36.7% of flowShareISIN DE000A40QVM8BAFIN:40035913-367b49115a6d
Canonical exit: 31 May 2026 (T+90)
10,000 shares@ €91.376.1% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-7d694b56aca0
Canonical exit: 3 May 2026 (T+90)
4,899.744 shares@ €66.3340.4% of flowShareISIN DE000A40QVM8BAFIN:40035913-71f2130eca16
Canonical exit: 27 Apr 2026 (T+90)
4,899.744 shares@ €66.332.2% of flowShareISIN DE000A40QVM8BAFIN:40035913-0d58d49f737c
Canonical exit: 27 Apr 2026 (T+90)
91.997 shares@ €84.590.1% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-98be475748f1
Canonical exit: 27 Apr 2026 (T+90)
1,582.046 shares@ €84.170.9% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-ec4f9d335d9b
Canonical exit: 23 Apr 2026 (T+90)
58 shares@ €85.000.0% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-c4cbfc405bad
Canonical exit: 26 Apr 2026 (T+90)
2,774.062 shares@ €81.661.5% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-58c5a5de7aa7
Canonical exit: 22 Apr 2026 (T+90)
3,379.01 shares@ €81.681.8% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-1121e57b1b1c
Canonical exit: 21 Apr 2026 (T+90)
1,613.02 shares@ €83.710.9% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-7b5b3cbf1795
Canonical exit: 20 Apr 2026 (T+90)
883.996 shares@ €84.870.5% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-7aefbbeeff36
Canonical exit: 19 Apr 2026 (T+90)
1,399.06 shares@ €84.880.8% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-dec35bd6355c
Canonical exit: 15 Apr 2026 (T+90)
13,255.594 shares@ €94.078.3% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-60765ba5d913
Canonical exit: 9 Mar 2026 (T+90)
10,713.595 shares@ €99.337.1% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-d3f61ad796b0
Canonical exit: 10 Mar 2026 (T+90)
7,499.842 shares@ €91.844.6% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-760e4753a2af
Canonical exit: 8 Mar 2026 (T+90)
1,050.023 shares@ €92.0912.0% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-ddb3225ec285
Canonical exit: 8 Mar 2026 (T+90)
799.991 shares@ €108.570.6% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-890a22b32dab
Canonical exit: 25 Nov 2025 (T+90)
199.998 shares@ €108.572.7% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-2dcd91211bb2
Canonical exit: 25 Nov 2025 (T+90)
6,400.219 shares@ €104.984.5% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-1419b88a9a79
Canonical exit: 24 Nov 2025 (T+90)
6,400.248 shares@ €103.074.4% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-02129e941793
Canonical exit: 23 Nov 2025 (T+90)
1,600.055 shares@ €104.9820.9% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-7329867542c1
Canonical exit: 24 Nov 2025 (T+90)
1,600.062 shares@ €103.0720.5% of flowShareXETRAISIN DE000A40QVM8BAFIN:40035913-0d309549844d
Canonical exit: 23 Nov 2025 (T+90)
25 of 27 declarations
About innoscripta SE
Geographically, innoscripta remains strongly anchored in its home market of Germany while expanding internationally. The group has established offices in Austria, Cologne and Istanbul, and in 2026 it announced new offices in France near Toulouse and in the United States, with additional UK development also highlighted. This expansion is designed to capture growing demand for R&D incentives across OECD markets, where tax-based support mechanisms and documentation requirements are becoming increasingly important. Recent corporate milestones include its IPO and first trading day on May 23, 2025 in the Scale segment, the legal conversion into innoscripta SE, and management’s stated push for further international growth. For investors, the equity story combines software scalability, regulatory tailwinds and an expanding geographic footprint, while remaining exposed to changes in subsidy frameworks and market adoption of R&D compliance tools.
Recent ranked signals in the same sector
Purchases our model currently ranks for the recommendations list.
All recommendations
